Conagen and Sumitomo Chemical, Japan's leading chemical company develop together p-hydroxystyrene (HS) and its polymer, poly p-hydroxystyrene (PHS), using a combination of biosynthesis, chemosynthesis and polymerization.
Conagen and Sumitomo Chemical jointly develop a new era of renewable carbon materials
August 01, 2023 04:00 ET | Conagen
Bedford, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Conagen, the bioplatform innovator and biomanufacturer, and Sumitomo Chemical, Japan's leading chemical company, have announced to jointly develop...
Sweegen exhibits at Food Ingredients Europe 2022
Sweegen announces growth capital investments and manufacturing partnership ahead of Food Ingredients Europe 2022
December 05, 2022 13:15 ET | Sweegen
Rancho Santa Margarita, Calif., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Sweegen announced its strategic investment and partnership snapshot ahead of the FI Europe 2022, where it will exhibit zero sugar...
Conagen Receives a Strategic Investment from Sumitomo Chemical
March 31, 2020 15:51 ET | Conagen
Bedford, Mass., March 31, 2020 (GLOBE NEWSWIRE) -- Greater Boston-based biotech Conagen has received a strategic investment from Sumitomo Chemical, global chemical company in Japan. The investment...
SWEEGEN RECEIVES STR
SWEEGEN RECEIVES STRATEGIC INVESTMENT FROM SUMITOMO CHEMICAL AND OUTLOOK INVESTMENT GROUP
October 08, 2019 16:30 ET | SweeGen, Inc.
Rancho Santa Margarita, Calif., Oct. 08, 2019 (GLOBE NEWSWIRE) -- SweeGen, Inc., a stevia-based sweetener company has received an additional strategic investment from and led by Sumitomo Chemical, a...
20170406 Telix Logo.png
Telix and Nihon Medi-Physics to Collaborate on Renal Cancer Imaging for the Japanese Market MELBOURNE, Australia and KYOTO, Japan and TOKYO, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company...